Jeremy To
Overview
Explore the profile of Jeremy To including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
To J, Quackenbush D, Rowell E, Li L, Reed C, Lo F, et al.
Commun Biol
. 2021 Aug;
4(1):1032.
PMID: 34453092
No abstract available.
2.
Grandhi T, To J, Romero A, Luna F, Barnes W, Walker J, et al.
Biotechnol Bioeng
. 2021 May;
118(8):3187-3199.
PMID: 34050941
Cancer is a disease of somatic mutations. These cellular mutations compete to dominate their microenvironment and dictate the disease outcome. While a therapeutic approach to target-specific oncogenic driver mutations helps...
3.
To J, Quackenbush D, Rowell E, Li L, Reed C, Lo F, et al.
Commun Biol
. 2021 Jan;
4(1):56.
PMID: 33420321
Overcoming tumor-mediated immunosuppression and enhancing cytotoxic T-cell activity within the tumor microenvironment are two central goals of immuno-oncology (IO) drug discovery initiatives. However, exploratory assays involving immune components are often...
4.
Emilsson V, Ilkov M, Lamb J, Finkel N, Gudmundsson E, Pitts R, et al.
Science
. 2018 Aug;
361(6404):769-773.
PMID: 30072576
Proteins circulating in the blood are critical for age-related disease processes; however, the serum proteome has remained largely unexplored. To this end, 4137 proteins covering most predicted extracellular proteins were...
5.
Horman S, To J, Lamb J, Zoll J, Leonetti N, Tu B, et al.
Oncotarget
. 2017 Dec;
8(59):99913-99930.
PMID: 29245949
Recent advances in chemotherapeutics highlight the importance of molecularly-targeted perturbagens. Although these therapies typically address dysregulated cancer cell proteins, there are increasing therapeutic modalities that take into consideration cancer cell-extrinsic...
6.
Horman S, To J, Orth A
J Biomol Screen
. 2013 Aug;
18(10):1298-308.
PMID: 23918920
There has been increasing interest in the development of cellular behavior models that take advantage of three-dimensional (3D) cell culture. To enable assessment of differential perturbagen impacts on cell growth...